Dose-dependent changes in the locomotor responses to methamphetamine in BALB/c mice: Low doses induce hypolocomotion

The overall goal of the present study was to determine the effects of different doses of (+)-methamphetamine (meth) on locomotor activity of Balb/C mice. Four experiments were designed to test a wide range of meth doses in BALB/c female mice. In Experiment 1, we examined locomotor activity induced by an acute administration of low doses of meth (0.01 and 0.03mg/kg) in a 90-min session. Experiment 2 was conducted to test higher meth doses (0.3-10mg/kg). In Experiment 3, separate sets of mice were pre-treated with various meth doses once or twice (one injection/week) prior to a locomotor challenge with a low meth dose. Finally, in Experiment 4, we tested whether locomotor activation would be affected by pretreatment with a low or moderate dose of meth one month prior to the low meth dose challenge. Results show that low doses of meth induce hypolocomotion whereas moderate to high doses induce hyperlocomotion. Prior exposure to either one moderate or high dose of meth or to two, low doses of meth attenuated the hypolocomotor effect of a low meth dose one week later. This effect was also attenuated in mice tested one month after administration of a moderate meth dose. These results show that low and high doses of meth can have opposing effects on locomotor activity. Further, prior exposure to the drug leads to tolerance, rather than sensitization, of the hypolocomotor response to low meth doses.

[1]  S. Shoptaw,et al.  Psychiatric and Substance Dependence Comorbidities, Sexually Transmitted Diseases, and Risk Behaviors Among Methamphetamine-Dependent Gay and Bisexual Men Seeking Outpatient Drug Abuse Treatment , 2003, Journal of psychoactive drugs.

[2]  I. Grant,et al.  Is hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence? , 2007, The American journal on addictions.

[3]  F. George Cocaine produces low dose locomotor depressant effects in NBR and F344 rats , 1990, Pharmacology Biochemistry and Behavior.

[4]  R. Rawson,et al.  Methamphetamine dependence and human immunodeficiency virus risk behavior. , 2008, Journal of substance abuse treatment.

[5]  Rivière Gj,et al.  SPONTANEOUS LOCOMOTOR ACTIVITY AND PHARMACOKINETICS OF INTRAVENOUS METHAMPHETAMINE AND ITS METABOLITE AMPHETAMINE IN THE RAT , 1999 .

[6]  N. Mataga,et al.  Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. , 1983, European journal of pharmacology.

[7]  K. Rice,et al.  Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.

[8]  Y. Yook,et al.  PRECLINICAL STUDY: Proteomic analysis of methamphetamine‐induced reinforcement processes within the mesolimbic dopamine system , 2008, Addiction biology.

[9]  S. M. Owens,et al.  Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons , 2006, Psychopharmacology.

[10]  A. Weinstein,et al.  Pharmacological approaches to methamphetamine dependence: a focused review. , 2010, British journal of clinical pharmacology.

[11]  G. Hanson,et al.  Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. , 2007, Addiction.

[12]  T. Robbins,et al.  A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats , 2004, Psychopharmacologia.

[13]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[14]  S. M. Owens,et al.  Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats. , 2005, European journal of pharmacology.

[15]  D. Kavanagh,et al.  Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users. , 2009, Addictive behaviors.

[16]  Jean Logan,et al.  Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study , 2002, Synapse.

[17]  G. Hanson,et al.  New insights into the mechanism of action of amphetamines. , 2007, Annual review of pharmacology and toxicology.

[18]  P. H. Andersen,et al.  Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. , 1990, European journal of pharmacology.

[19]  K. Kitahama,et al.  Strain differences in amphetamine sensitivity in mice , 1979, Psychopharmacology.

[20]  T. Macedo,et al.  Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase‐3 in caudate‐putamen , 2006, Synapse.

[21]  D. Weinshenker,et al.  Perspective There and Back Again : A Tale of Norepinephrine and Drug Addiction , 2007 .

[22]  H. Loh,et al.  μ‐Opioid receptor knockout mice are insensitive to methamphetamine‐induced behavioral sensitization , 2010, Journal of neuroscience research.

[23]  J. Maxwell Emerging research on methamphetamine , 2005, Current opinion in psychiatry.

[24]  N. Volkow,et al.  Drug addiction: the neurobiology of behaviour gone awry , 2004, Nature Reviews Neuroscience.

[25]  T. Archer,et al.  Effects of clonidine and α-adrenoceptor antagonists on motor activity in DSP4-treated mice I: Dose-, time- and parameter-dependency , 1999, Neurotoxicity Research.

[26]  Leanne Hides,et al.  The prevalence of psychotic symptoms among methamphetamine users. , 2006, Addiction.

[27]  S. M. Owens,et al.  Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague–Dawley rats , 2007, Pharmacology Biochemistry and Behavior.

[28]  S. Iversen,et al.  The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat , 2004, Psychopharmacologia.

[29]  S. Batki,et al.  Stimulant psychosis: symptom profile and acute clinical course. , 2000, The American journal on addictions.

[30]  T. Dawson,et al.  Methamphetamine-induced reduction in D1 and D2 dopamine receptors as evidenced by autoradiography: Comparison with tyrosine hydroxylase activity , 1987, Neuroscience.

[31]  W. Haning,et al.  Electrocardiographic abnormalities in methamphetamine abusers. , 2007, Addiction.

[32]  Rita Z. Goldstein,et al.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. , 2002, The American journal of psychiatry.

[33]  M. Nomoto,et al.  Effects of GBR 12909 on locomotor activity and dopamine turnover in mice: comparison with apomorphine. , 1995, European journal of pharmacology.

[34]  Clonidine-induced hypoactivity and mydriasis in mice are respectively mediated via pre- and postsynaptic alpha 2-adrenoceptors in the brain. , 1989, European journal of pharmacology.

[35]  S. Iversen,et al.  Proceedings: Amphetamine and apomorphine responses in the rat after lesion of mesolimbic or striatal dopamine neurones. , 1975, British journal of pharmacology.

[36]  K. Berridge,et al.  The incentive sensitization theory of addiction: some current issues , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[37]  M. Leist,et al.  Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels , 2007, Brain Research.

[38]  E. Bartlett,et al.  Selective Sensitization to the Psychosis-Inducing Effects of Cocaine: A Possible Marker for Addiction Relapse Vulnerability? , 1997, Neuropsychopharmacology.

[39]  T. Kosten,et al.  Substance Abuse Vaccines , 2008, Annals of the New York Academy of Sciences.

[40]  S. M. Owens,et al.  (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration , 2004, Pharmacology Biochemistry and Behavior.

[41]  F. Carroll,et al.  Effects of Murine-Derived Anti-Methamphetamine Monoclonal Antibodies on (+)-Methamphetamine Self-Administration in the Rat , 2004, Journal of Pharmacology and Experimental Therapeutics.

[42]  Syed F. Ali,et al.  Behavioral Consequences of Methamphetamine‐Induced Neurotoxicity in Mice: Relevance to the Psychopathology of Methamphetamine Addiction , 2002, Annals of the New York Academy of Sciences.

[43]  R. A. Sewell,et al.  REVIEW: Norepinephrine and stimulant addiction , 2009, Addiction biology.

[44]  James Robert Brašić,et al.  Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users , 2008, Synapse.